August 2018
ProMedica Health System in New Joint Venture Partnership
Sonic Healthcare USA
Thursday, 02 August 2018
Sonic Healthcare USA (Sonic Healthcare) and ProMedica Health System (ProMedica) announced that they have entered into a definitive agreement to form a joint venture to enhance laboratory services f...
March 2019
AEL Awarded Preferred Plus Network Status with Blue Cross and Blue Shield of Alabama
Austin, TX
Monday, 25 March 2019
American Esoteric Laboratories (AEL), a division of Sonic Healthcare USA (Sonic Healthcare), has announced that it will be a Blue Cross and Blue Shield of Alabama (BCBSAL) Preferred Medical Labora...
April 2019
New Data on Diagnostic and Therapeutic Applications of ThyroSeq® Genomic Classifier
Austin, TX
Friday, 26 April 2019
Data from three studies demonstrating new diagnostic and therapeutic utility of ThyroSeq® Genomic Classifier, offered commercially by CBLPath, a Sonic Healthcare Company, are being presented at...
ThyroSeq Data Presented at the 2019 American Association of Clinical Endocrinologists Annual Meeting
Austin, TX
Monday, 29 April 2019
Validation of ThyroSeq® Genomic Classifier performance in an expanded range of sample types has been presented at the 28th Annual Scientific and Clinical Congress of the American Association of C...
November 2019
Exclusive License Agreement with UPMC for Broader Patient Access to the ThyroSeq® Genomic Classifier
Austin, TX
Tuesday, 05 November 2019
Sonic Healthcare USA (Sonic) and UPMC have entered into an exclusive long-term, 15-year license agreement for access to ThyroSeq® Genomic Classifier. The test has already been commercially availab...
March 2020
Clinical Laboratory Executives Met with the White House's Coronavirus Taskforce
Austin, TX
Friday, 06 March 2020
This week, Academic and Commercial Reference Laboratory Executives met with Vice President, Mike Pence and members of the White House's Coronavirus Task Force to collectively discuss diagnostic yes...
Sonic Healthcare USA Announces Testing Availability for COVID-19
Austin, TX
Friday, 13 March 2020
This week, Sonic Healthcare USA's network of clinical laboratories began testing for SARS-CoV-2 (COVID-19). Sonic Healthcare USA has worked closely with its scientific partners and medical and oper...
April 2020
Expanding Testing Capabilities by Launching COVID-19 Antibody Testing
Austin, TX
Tuesday, 28 April 2020
Sonic Healthcare USA's network of clinical laboratories has begun performing antibody testing for SARS-CoV-2 (COVID-19) to complement our existing molecular PCR testing. Sonic Healthcare USA labora...
Sonic Healthcare USA Develops Novel Return-to-Work Protocol
Austin, TX
Thursday, 30 April 2020
Sonic Healthcare USA's COVID-19 Taskforce Medical and Scientific Advisors have developed a novel Return-to-Work protocol consisting of laboratory testing algorithms intended to help guide employers...
SARS-CoV-2 (COVID-19) Media Statement
Friday, 03 April 2020
Sonic Healthcare USA’s dedicated scientific, medical and operational experts have established SARS-CoV-2/COVID-19 testing in six of our laboratories across the country since March 10, 2020. Our res...
May 2020
Sonic Healthcare USA Hosts U.S. Health and Human Services Secretary
Austin, TX
Tuesday, 26 May 2020
Sonic Healthcare USA's Bernhardt Laboratories, located in Jacksonville, Florida, hosted U.S. Health and Human Services Secretary Alex Azar at their facility last week. Bernhardt Laboratories is an...
June 2020
American Clinical Laboratory Association Update on COVID-19 Testing Capacity
Tuesday, 30 June 2020
WASHINGTON, D.C – Following a surge of new COVID-19 cases in the United States, ACLA President Julie Khani issued the following statement:
July 2020
Sonic Healthcare USA SARS-CoV-2 (COVID-19) Media Statement
Thursday, 02 July 2020
Over the last few weeks, our network of clinical laboratories throughout the United States has seen a significant increase in demand for COVID-19 molecular testing.
New Study Validates Cytology Smears as an Alternative Sample Type for ThyroSeq Testing
Wednesday, 22 July 2020
A new validation study published today, “Thyroid Cytology Smear Slides: An Untapped Resource for ThyroSeq Testing."
September 2020
Today, Sonic Healthcare USA (Sonic) was awarded a contract from the National Institutes of Health (NIH) Rapid Acceleration of Diagnostics Advanced Technology Platforms (RADx-ATP) initiative.
October 2020
Sonic Healthcare USA Enhances Test Offerings with the Launch of Multiplex Assay for COVID-19 and Flu
Wednesday, 07 October 2020
Sonic Healthcare USA has launched a multiplex RT-PCR assay that combines testing for SARS-CoV-2 (COVID-19) and Influenza A/B with a single specimen collection.
April 2021
Sonic Healthcare USA is announced as a Laboratory Testing Partner for National K-12 School Testing Program
Sonic Healthcare USA
Monday, 19 April 2021
Sonic Healthcare USA is announced as a Laboratory Testing Partner for National K-12 School Testing Program
July 2021
Sonic Healthcare USA to Offer Assay to Aid in the Selection of JEMPERLI (dostarlimab-gxly) Therapy in Endometrial Cancer
Austin, TX
Friday, 02 July 2021
LMC Pathology Services (LMC), a Sonic Healthcare USA Anatomic Pathology Practice, is the first reference laboratory in the United States to offer the VENTANA MMR RxDx...
December 2021
SARS-CoV-2 Omicron Variant of Concern
Sonic Healthcare USA
Wednesday, 22 December 2021
SARS-CoV-2 Omicron Variant of Concern
July 2022
Sonic Healthcare USA authorized by HHS to perform testing for the Monkeypox Virus
Tuesday, 05 July 2022
Sonic Healthcare USA (Sonic) was selected as one of five commercial laboratories authorized by the US Department of Health and Human Services (HHS)...
Sonic Healthcare USA Announces Testing Availability for Monkeypox
Monday, 18 July 2022
This week, Sonic Healthcare USA (Sonic) began testing for Monkeypox (MPXV), using the Centers for Disease Control and Prevention (CDC) Non-variola Orthopoxvirus, high complexity NAAT (RT-PCR) molecular assay...
May 2023
Proteomics International Laboratories Ltd (Proteomics International; the Company; ASX: PIQ) is pleased to announce it has signed an exclusive license agreement with Sonic Healthcare USA, a Division of Sonic Healthcare Ltd (OTCMKTS: SKHHY) for the use and commercialization of the Company's PromarkerD test for diabetic kidney disease in the United States. Proteomics International Laboratories Ltd (Proteomics International; the Company; ASX: PIQ) is pleased to announce it has signed an exclusive license agreement with Sonic Healthcare USA, a Division of Sonic Healthcare Ltd (OTCMKTS: SKHHY) for the use and commercialization of the Company's PromarkerD test for diabetic kidney disease in the United States. Under the agreement, Sonic Healthcare USA will be offering PromarkerD to physicians and healthcare systems through its client engagement teams across the US...
October 2023
Sonic Healthcare USA Donating $100K to Maui Relief
Monday, 30 October 2023
In the devastation that followed the tragic wildfires this past August, burning through hundreds of acres on the island of Maui, two of our Clinical Laboratories of Hawaii (CLH) locations in the Lahaina area suffered overwhelming loss...